The stilbene phytochemicals resveratrol and piceatannol have been reported to possess substantial antitumorigenic and antileukemic activities, respectively. Although recent experimental data revealed the proapoptotic potency of resveratrol, the molecular mechanisms underlying the antileukemic activity have not yet been studied in detail. In the present study, we show that resveratrol, as well as the hydroxylated analog piceatannol, are potent inducers of apoptotic cell death in BJAB Burkittlike lymphoma cells with an ED 50 concentration of 25 M. Further experiments revealed that treatment of BJAB cells with both substances led to a concentration-dependent activation of caspase-3 and mitochondrial permeability transition. Using BJAB cells overexpressing a dominant-negative mutant of the Fas-associated death domain (FADD) adaptor protein to block death receptor-mediated apoptosis, we demonstrate that resveratrol-and piceatannol-induced cell death in these cells is independent of the CD95/Fas signaling pathway. To explore the antileukemic properties of both compounds in more detail, we extended our study to primary, leukemic lymphoblasts. Interestingly, piceatannol but not resveratrol is a very efficient inducer of apoptosis in this ex vivo assay with leukemic lymphoblasts of 21 patients suffering from childhood lymphoblastic leukemia (ALL). Leukemia (2001Leukemia ( ) 15, 1735Leukemia ( -1742 
Introduction
Polyhydroxylated stilbenes are natural products which can be extracted from different plants and have been widely used for treating tumors, cancer and warts. 1 For example, resveratrol (trans-4,3Ј,5Ј-trihydroxystilbene, for chemical structure see Figure 1 ) is found in relatively high concentrations in grape berry skins, 2 whereas piceatannol (trans-3,4,3Ј,5Ј-tetrahydroxystilbene, for chemical structure see also Figure 1 ) was identified as an antileukemic agent from the seeds of Euphorbia lagascae. 3 As a phenolic compound, resveratrol possesses antioxidant potential and thereby may play a role in the prevention of cardiovascular diseases when moderately consumed as an ingredient of red wine. 4, 5 Furthermore, in assays representing three major stages of carcinogenesis, resveratrol has been identified as a potent chemopreventive agent. 6 This remarkable effect has been mainly attributed to the ability of resvera- 
Figure 1
Chemical structures of resveratrol and piceatannol.
trol to inhibit cellular events associated with cell growth, eg inhibition of cyclooxygenase-1 (COX-1) and ribonucleotide reductase activity (for review see Ref. 2 2 ). Moreover, several reports showed a proapoptotic effect of resveratrol in different cancer cell lines. [7] [8] [9] Since reduced apoptosis (programmed cell death) induction has been implicated in the development and progression of malignant tumors 10, 11 and in the occurrence of chemoresistant phenotypes [12] [13] [14] [15] resveratrol-induced apoptosis might therefore contribute to its antitumorigenic activities.
Despite its chemical similarity to resveratrol and its longknown antileukemic properties, piceatannol-induced cell death has not yet been studied. Instead, most researchers focussed their interest on the kinase-inhibiting properties of piceatannol and it has been shown that this compound is a naturally occurring protein-tyrosine kinase inhibitor. 16 Piceatannol is widely used as a selective inhibitor of the receptorassociated protein-tyrosine kinase Syk, [17] [18] [19] but evidence has been provided that piceatannol also interferes with other kinases, such as rat brain protein kinase C or Ca 2+ -calmodulindependent myosin light chain kinase. 20 Screening of a series of polyhydroxylated analogs of piceatannol revealed that reduction of the double bond bridging the two aromatic rings and benzylation of the phenolic hydroxyl groups significantly reduced the protein-tyrosine kinase inhibitory activity of the compounds. 21 Thus, it seems likely that the biological effects of polyhydroxylated stilbenes depend on the number of their phenolic hydroxyl groups.
In the present study, the proapoptotic properties of resveratrol and its hydroxylated analog, piceatannol, were investigated in the lymphoma cell line BJAB. We show that both compounds induce apoptosis, as evidenced by measurement of DNA fragmentation, without affecting plasma membrane permeability. The analysis of the signaling requirements showed that both resveratrol-and piceatannol-induced cell death is executed via the mitochondrial apoptosis pathway as determined by loss of the mitochondrial membrane potential followed by activation of caspase-3. We clearly exclude, as previously shown for drug-induced apoptosis, 22 that cell death proceeded in a CD95/Fas-dependent manner. Interestingly, the antileukemic effect of the two analogs greatly differed in primary lymphoblasts from ALL patients although the proapoptotic effects of the two analogs were nearly identical in BJAB cells. Whereas resveratrol only induced modest apoptosis in this ex vivo assay of primary lymphoblasts, piceatannol exerted a considerable proapoptotic effect. These data strongly suggest that piceatannol is an antileukemic agent with potential potency for clinical use.
Materials and methods

Materials
Polyclonal rabbit anti-human caspase-3 (developed against human recombinant protein) and polyclonal rabbit antihuman Rho-GDI/D4-GDI (developed against full-length recombinant human Rho-GDI-1) antibodies were from PharMingen (Hamburg, Germany). Agonistic, monoclonal anti-CD95 antibody was diluted into growth medium to give a final concentration of 1 g/ml. Secondary anti-rabbit horseradish peroxidase (HRP)-conjugated antibodies were from Promega (Mannheim, Germany). RNase A was from Roth (Karlsruhe, Germany). Resveratrol and piceatannol were from Alexis (Grü nberg, Germany). The caspase-3 inhibitor zDEVDfmk (in which z stands for benzyloxycarbonyl and fmk for fluoromethyl ketone) was from Kamiya Biomedical Company (Seattle, WA, USA). Resveratrol and piceatannol were stored as 40 mM stock solutions in ethanol at −20°C and diluted into growth media for experiments. Ethanol (vehicle) was added to controls and was present at 0.25% or less in the experiments. 0.25% ethanol did not induce significant DNA fragmentation as compared with growth medium treated cells (data not shown). The dominant negative FADD construct (FADDdn) was a kind gift from AM Chinnaiyan and VM Dixit (University of Michigan, Ann Arbor, MI, USA).
Patients
Samples containing at least 5 × 10 7 cells of 21 children with ALL were analyzed in this study. Out of 21 patients, seven were female and 14 were male. The diagnosis was established by immunophenotyping of leukemia cells according to Béné et al. 23 The median age at diagnosis was 8 years (range 1 to 16 years). Patients with ALL in this study had been entered into therapy protocols from the Gesellschaft fü r Pädiatrische Onkologie und Hämatologie (GPOH).
24-26
Cell culture
Control vector-(pcDNA3-mock-transfected) and pcDNA3-FADDdn-transfected BJAB cells, which were stably transfected with a dominant-negative FADD mutant lacking the N-terminal death effector domain, 27 were grown in RPMI 1640 medium supplemented with 10% fetal calf serum, 0.56 g/l lglutamine, 100 000 U/l penicillin and 0.1 g/l streptomycin.
Media and culture reagents were from Life Technologies GmbH (Karlsruhe, Germany). BJAB cells were subcultured every 3-4 days by dilution of the cells to a concentration of 1 × 10 5 cells/ml. Additionally, leukemic samples from patients with childhood ALL were obtained by bone marrow aspiration. Lymphoblasts and mononuclear cells were separated by centrifugation over Ficoll. After separation, the percentage of leukemic lymphoblasts was above 90% which is in accordance with a former study.
14 Leukemic lymphoblasts were immediately seeded at a density of 3 × 10 5 cells/ml in RPMI 1640 complete cell culture medium and treated with different concentrations of resveratrol or piceatannol for up to 72 h.
Measurement of cell death
Cytotoxicity of the different drugs was measured by the release of lactate dehydrogenase (LDH) as described previously. 28 After incubation with different concentrations of resveratrol or piceatannol for 4 h, LDH activity released by BJAB cells was measured in the cell culture supernatants using the Cytotoxicity Detection Kit from Boehringer Mannheim (Mannheim, Germany). The supernatants were centrifuged at 300 g for 5 min. Twenty l of cell-free supernatants were diluted with 80 l phosphate-buffered saline (PBS) and 100 l reaction mixture containing 2-[4-iodophenyl]-3-[4-nitrophenyl]-5-phenyltetrazolium chloride (INT), sodium lactate, NAD + and diaphorase were added. Then, time-dependent formation of the reaction product was quantified photometrically at 490 nm. The maximum amount of LDH activity released by the cells was determined by lysis of the cells using 0.1% Triton X-100 in culture medium and set as 100% cell death.
Measurement of DNA fragmentation
DNA fragmentation was measured essentially as described. 29 Briefly, cells were seeded at a density of 1 × 10 5 cell/ml and treated with different concentrations of resveratrol or piceatannol. After 60 h, cells were collected by centrifugation at 300 g for 5 min, washed with PBS at 4°C and fixed in PBS/2% (v/v) formaldehyde on ice for 30 min. After fixation, cells were incubated with ethanol/PBS (2:1, v/v) for 15 min, pelleted and resuspended in PBS containing 40 g/ml RNase A. After incubation for 30 min at 37°C, cells were pelleted again and finally resuspended in PBS containing 50 g/ml propidium iodide. Nuclear DNA fragmentation was then quantified by flow cytometric determination of hypodiploid DNA. Data were collected and analyzed using a FACScan (Becton Dickinson, Heidelberg, Germany) equipped with the CELLQuest software. Data are given in % hypoploidy (subG1), which reflects the number of apoptotic cells.
Immunoblotting
After incubation for 36 h with different concentrations of resveratrol or piceatannol, BJAB cells were washed twice with PBS and lysed in buffer containing 10 mm Tris/HCl, pH 7.5, 300 mm NaCl, 1% Triton X-100, 2 mM MgCl 2 , 5 m (ethylenediamino) tetraacetic acid (EDTA), 1 m pepstatin, 1 m leupeptin and 0.1 mm phenylmethylsulfonyl fluoride (PMSF). Protein concentration was determined using the bicinchoninic acid assay 30 from Pierce (Rockford, IL, USA) and equal amounts of protein (usually 20 g per lane) were separated by SDS-PAGE. 31 Then, immunoblotting was performed as described. 32 Membranes (Schleicher and Schuell, Dassel, Germany) were swollen in CAPS-buffer (10 mm 3-(cyclohexylamino)propane-1-sulphonic acid (CAPS), pH 11, 10% MeOH) for several minutes and blotting was performed at 1 mA/cm 2 for 1 h in a transblot SD cell (BioRad, Mü nchen, Germany). The membrane was blocked for 1 h in PBST (PBS, 0.05% Tween-20) containing 3% non-fat dry milk and incubated with primary anti-human caspase-3 or anti-human Rho-GDI/D4-GDI antibody for 1 h. After the membrane had been washed three times in PBST, secondary antibody in PBST was applied for 1 h. Finally, the membrane was washed in PBST again and protein bands were detected using the ECL enhanced chemiluminescence system (Amersham Buchler, Braunschweig, Germany).
Measurement of the mitochondrial permeability transition
After incubation with different concentrations of resveratrol or piceatannol, BJAB cells were collected by centrifugation at 300 g, 4°C for 5 min. Mitochondrial permeability transition was then determined by staining the cells with 5,5Ј,6, 6Ј-tetrachloro-1,1Ј,3,3Ј-tetraethyl-benzimidazolylcarbocyanin iodide (JC-1; Molecular Probes, Leiden, The Netherlands) as described.
33,34 1 × 10 5 cells were resuspended in 500 l phenol red-free RPMI 1640 without supplements and JC-1 was added to give a final concentration of 2.5 g/ml. The cells were incubated for 30 min at 37°C and moderate shaking. Control cells were likewise incubated in the absence of JC-1 dye. The cells were harvested by centrifugation at 300 g, 4°C for 5 min, washed with ice-cold PBS and resuspended in 200 l PBS at 4°C. Mitochondrial permeability transition was then quantified by flow cytometric determination of cells with decreased fluorescence, ie with mitochondria displaying a lower membrane potential. Data were collected and analyzed using a FACScan (Becton Dickinson) equipped with the CELLQuest software. Data are given in % cells with low ⌬⌿ m , which reflects the number of cells undergoing mitochondrial apoptosis.
Statistical analysis
Apoptosis induction by resveratrol and piceatannol in the lymphoblasts of 21 patients with childhood ALL was analyzed by the paired Wilcoxon signed rank test.
Results
Resveratrol and piceatannol specifically induce apoptotic DNA fragmentation in the Burkitt-like lymphoma cell line BJAB
Depending on the concentration, treatment of mammalian cells with amphiphilic substances might lead to necrotic, membrane-damaging cell death as well as apoptotic cell death. 28 Thus, we first measured the unspecific, cytotoxic effect of resveratrol and piceatannol in BJAB cells after 4 h of incubation by determination of LDH release into the culture
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Figure 2
Unspecific, cytotoxic effects of resveratrol and piceatannol. BJAB cells were treated with different concentrations of resveratrol (open circles) or piceatannol (closed circles). After 4 h of incubation, viability was determined by the LDH release assay as described in Materials and methods. Values of viability are given in % ± s.d. (n = 3).
medium. As shown in Figure 2 , neither resveratrol nor piceatannol at concentrations р100 m significantly reduced viability of BJAB cells thereby indicating that a membranedisrupting effect of these naturally occurring polyhydroxystilbenes, ie unspecific necrosis, does not play a role for their death-inducing potency. In contrast, when cell death was measured by a modified cell cycle analysis which detects DNA fragmentation on the single cell level, both compounds potently induced apoptosis in up to 40% of the cells ( Figure  3) . Apoptosis induction was concentration-dependent with a half-maximum concentration of 25 m for both resveratrol and piceatannol. Thus, in BJAB cells, the two analogs resveratrol and piceatannol are specific proapoptotic agents with nearly identical efficiency. Their apoptotic potency in BJAB cells is thereby comparable to the activity of conventional cytotoxic drugs, such as anthracyclins and taxanes. 
Resveratrol-and piceatannol-induced apoptosis in BJAB cells is mediated by loss of mitochondrial membrane potential and caspase-3 activation
In principle, execution of apoptotic cell death can be mediated by different signaling pathways, originating at the cell membrane (death receptors), the mitochondrion or the endoplasmic reticulum. 11 However, these pathways converge at the level of caspase-3 which represents the main executioner caspase in mammalian cells. 35, 36 In a previous study, we described the hierarchical activation of mitochondria and caspase-3 after challenge of B-lymphoid cells with cytotoxic drugs, eg Taxol and epirubicin. 22 Interestingly, resveratrol as well as piceatannol led to a significant loss of the mitochondrial membrane potential at relatively low concentrations of 15 and 25 m (Figure 4) thereby showing that both substances utilize the mitochondrial apoptosis machinery in the respective death signaling pathway.
To gain further insight into resveratrol-and piceatannolinduced cell death, the involvement of caspase-3 was investigated by Western blot analysis. Challenge of BJAB cells with 5, 15 and 25 m resveratrol or piceatannol led to processing of procaspase-3 and the appearance of the 17 kDa active subunit of caspase-3 ( Figure 5 , upper panel). We further demonstrated resveratrol-and piceatannol-induced activation of caspase-3 by detecting concentration-dependent cleavage of the caspase-3-specific substrate, D4-GDI. 29 As shown in Figure 5 , treatment of BJAB cells with 5, 15 and 25 m resveratrol or piceatannol evoked the cleavage of D4-GDI which resulted in the appearance of the 23 kDa cleavage product. Furthermore, we demonstrated a functional role of caspase-3 in stilbene-induced apoptosis by using the specific, cell-permeable caspase-3 inhibitor, zDEVD-fmk. In these experiments, zDEVD-fmk partially inhibited resveratrol-, as well as piceatannol-induced DNA fragmentation and D4-GDI cleavage (data not shown). Taken together, the data presented above clearly show the importance of caspase-3 activation in stilbene-induced apoptosis. 
Resveratrol-and piceatannol-induced apoptosis occurs independently of CD95/Fas signaling in BJAB cells
As shown above, resveratrol-and piceatannol-induced apoptosis in B cells occurred via activation of mitochondria and caspase-3 thereby pointing to the mitochondrial death pathway. To formally exclude an involvement of the CD95/Fas or other death receptor systems, we used BJAB cells overexpressing a dominant-negative FADD mutant (FADDdn). Both mock and FADDdn transfectants express endogenous FADD (27 kDa), while the FADDdn transfectants also show a lower band representing the truncated FADDdn (data not shown). 22 To provide a positive control for the biological activity of the dominant negative FADD we functionally characterized the FADDdn overexpressing BJAB cells. In our hands, 69.5 ± 6.3% (n = 3) of control vector-transfected BJAB/mock cells were killed after treatment with 1 g/ml agonistic anti-CD95 antibody (death rate of BJAB/mock cells after treatment with growth medium: 12.6 ± 2.1% (n = 3)). In contrast, BJAB/FADDdn cells were completely resistant to treatment with agonistic anti-CD95 antibody. In the presence of 1 g/ml anti-CD95 only 18.9 ± 1.1% (n = 3) of BJAB/FADDdn cells died which was not significantly different from BJAB/FADDdn cells which had been incubated in the absence of anti-CD95 (16.8 ± 2.1% (n = 3)). These data clearly demonstrated the efficacy of FADDdn in these cells. However, in accordance with the hypothesis that resveratrol-and piceatannol-induced apoptosis in BJAB cells is independent of CD95/Fas signaling, caspase-3 cleavage (Figure 6a In recent publications, CD95/Fas-dependent signaling to mitochondria via caspase-8-mediated cleavage of Bid has been demonstrated. 37 We thus measured mitochondrial activation after treatment with resveratrol and piceatannol in BJAB/mock and BJAB/FADDdn cells. Treatment of BJAB/mock cells with both agents led to significant mitochondrial permeability transition and to an approximately 2.3-to three-fold increase of cells with low ⌬⌿ m after 36 h (Figure 6b ). However, this mitochondrial permeability transition was not inhibited by overexpression of FADDdn (Figure 6b) , thereby excluding the possibility that the mitochondrial activation in BJAB cells was mediated by a CD95/Fas-dependent mechanism.
Piceatannol, but not resveratrol, is a very efficient inducer of apoptosis in primary leukemic lymphoblasts
The use of cell lines to screen for the antileukemic properties of natural organic compounds is a reasonable and widespread experimental approach. However, especially in the case of childhood ALL, the use of cell lines might lead to misinterpretations of experimental results. For example, we and others have shown that p53 mutations are relatively rare in childhood ALL 14, 38 and occur in less than 10% of the patients. On the other hand, p53 mutations were found in 67% of 18 T cell ALL cell lines. 39 Thus, we decided to test the proapoptotic efficiency of resveratrol and piceatannol in a series of primary, leukemic lymphoblasts which were directly and freshly isolated from bone marrow aspirates of children with ALL.
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First, we established an ex vivo assay to measure apoptotic cell death in these cells. For this, leukemic lymphoblasts were immediately treated with 25 m resveratrol or piceatannol and incubated for 36 h. In this experimental setup, the apoptosis rate of control medium-treated cells was in the range of 15% and never exceeded 30% (see also Figure 8 ). Nevertheless, significant DNA fragmentation in drug-treated cells could readily be detected. Surprisingly, primary lymphoblasts were very sensitive towards treatment with 25 m piceatannol (23.3% specific apoptosis), whereas the same concentration of resveratrol only lead to very moderate specific apoptosis induction of 4.7% as compared with control cells (Figure 7a ). Similar results were obtained when the lymphoblasts were treated with 50 m resveratrol or 50 m piceatannol (Figure 7b ). We evaluated these preliminary results in lymphoblasts of a cohort of 21 children with ALL. As shown in Figure  8 , the proapoptotic effect of 25 m piceatannol was consistently higher as compared with the effect of 25 m resveratrol. Statistical analysis revealed this difference to be highly significant (P = 0.0015, Wilcoxon signed rank test). The higher efficacy of piceatannol in primary lymphoblasts was also observed at a concentration of 50 m (Figure 8 ; P = 0.0032, Wilcoxon signed rank test).
Discussion
In the present study, we could clearly demonstrate that polyhydroxystilbenes, ie resveratrol and piceatannol, induce apoptosis in BJAB lymphoma cells at concentrations ranging from 15 to 100 m. Our data together with reports from other laboratories showing resveratrol-induced apoptosis in HL60 leukemia cells 7, 9 indicate that apoptosis induction represents one molecular mechanism which accounts for the anticancer properties of resveratrol in the malignant lymphoblasts investigated in this study, at least at those concentrations mentioned above. Resveratrol is found in red wines of different origin and its concentration generally ranges between 0.4 and 65.8 m. Thus, resveratrol-mediated apoptosis may also contribute to the cancer chemopreventive properties of this compound as reported recently by Jang et al 6 and may in part explain the benefits of moderate wine consumption to health which has been indirectly shown by epidemiological studies. 4, 5 In the last years, a bulk of experimental work was performed to elucidate the molecular targets of resveratrol and piceatannol. It has been shown that resveratrol is a potent inhibitor of various enzymes, such as cyclooxygenase-1 and ribonucleotide reductase, 2 and suppresses NFB function 40 whereas piceatannol was found to be a selective protein-tyrosine kinase inhibitor. 16, 18, 19, 21 Interestingly, recent work provided evidence for a direct influence of polyhydroxystilbenes on mitochondrial functions, eg mitochondrial F 0 F 1 ATPase. 41, 42 Mitochondrial ATPase is located in the inner mitochondrial membrane and synthesizes ATP by utilization of the protonmotive force which is generated by the electron-transfer complexes of the respiratory chain. In this context, our results that treatment of BJAB cells with resveratrol or piceatannol led to a significant decrease of the mitochondrial membrane potential is intriguing. However, further investigations are necessary to show whether this decrease is directly caused by inhibition of the mitochondrial F 0 F 1 ATPase or is an indirect consequence of resveratrol-and piceatannol-induced apoptosis.
In a previous study, resveratrol-induced apoptosis in HL60 human leukemia cells and in T47D breast carcinoma cells was shown to be mediated by a Fas/CD95-dependent mech- 
Figure 8
Comparison of the proapoptotic effect of resveratrol and piceatannol in primary, leukemic lymphoblasts. Primary, leukemic lymphoblasts were treated with ethanol-containing growth medium (Control), 25 M resveratrol, 25 M piceatannol, 50 M resveratrol or 50 M piceatannol. After 36 h of incubation, DNA fragmentation was determined as described in Materials and methods. Box plots for control cells (n = 21), cells treated with 25 M resveratrol (n = 21), 25 M piceatannol (n = 21), 50 M resveratrol (n = 14) or 50 M piceatannol (n = 14) are shown and values of cells displaying hypodiploid DNA are given in % of the total population. P values were calculated using Wilcoxon signed rank test.
anism. 7 This is rather surprising since it is now clear, at least for conventional cytostatic drugs, that chemotherapy-induced cell death is independent from death ligand and death receptor signaling and proceeds via mitochondrial activation. 22, 43 In our hands, resveratrol-and piceatannol-induced apoptosis in BJAB cells was not blocked by overexpression of a dominant negative mutant of the adaptor molecule FADD, thereby indicating that cell death of B cells after challenge with these agents proceeds via a death receptor-independent pathway. This discrepancy, however, might also be explained by cell type-specific death signaling 44 as we have likewise shown for the cytotoxic drugs, taxol and epirubicin, in B lymphoid vs T lymphoid cells. 22 Although we have not measured cytochrome c release into the cytosol in BJAB cells or performed inhibitor experiments using Bcl-2 overexpression our results about resveratrol-and piceatannol-induced alterations of the mitochondrial membrane potential indicate that the cell death provoked by these compounds procedes via a mitochondrial pathway. Moreover, our data are in line with two recent publications which clearly showed that resveratrol induces apoptosis in tumor cell lines by a pathway which involves the depolarization of mitochondrial membranes 45 and is controlled by Bcl-2. 46 The use of primary lymphoblasts of patients suffering from childhood ALL revealed that piceatannol, but not resveratrol, is a very efficient inducer of apoptotic cell death and thus possesses antileukemic potential. Furthermore, we could demonstrate in these primary cells that piceatannol at 25 m was even more effective in our ex vivo apoptosis assay as compared with established chemotherapeutics, eg 5 g/ml daunorubicin (P = 0.0012, Wilcoxon signed rank test) (data not shown). This structure-dependent effect of piceatannol which seems to be dramatically influenced by benzylation of the phenolic hydroxyl group at the C4-position is astonishing. In a previous study, we have shown that during relapse of pediatric ALL a disturbance of apoptotic pathways occurs, 14 which might be responsible for the chemoresistant phenotype of these cells. Thus, our data indicate that only piceatannol, but not resveratrol, is able to circumvent the chemoresistance of the primary lymphoblasts, possibly by directly targeting mitochondrial F 0 F 1 -ATPase 42 or the receptor-associated protein-tyrosine kinase Syk. 17 Interestingly, a similar structuredependency but with opposite effects has been described in human liver myofibroblasts: whereas resveratrol deactivated cultured human liver myofibroblasts and decreased myofibroblast migration in a monolayer wounding assay, piceatannol did not reproduce these effects in identical assays. 47 The major drawback of chemotherapy is represented by the development of drug-resistant cell clones and dysfunction of apoptotic pathways may account for some aspects of this phenomenon. For example, it has been shown that chemoresistant relapse of childhood ALL is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo 14 and that resistance to CD95/Fas-induced apoptosis is caused by defective mitochondrial cytochrome c release in cultured human melanoma cells. 15 The search for new and effective agents and for new therapeutic strategies is therefore necessary. In this line, an interesting approach to overcome drug resistance by overexpression of the downstream apoptosis executioner, caspase-3, in its inactive proenzyme form has been described. Interestingly, retroviral gene transfer of procaspase-3 did not influence background apoptosis of the cells but significantly enhanced apoptosis induction by different chemotherapeutics in cells with defective mitochondrial signaling. 48 Because resveratrol, as well as piceatannol, clearly induced mitochondrial permeability transition in BJAB cells, the combination of the transfer of proapoptotic genes and the use of newly developed chemical agents with distinct cellular targets, eg mitochondrial F 0 F 1 ATPase, represents a promising approach for the treatment of chemoresistant cancers.
In summary, the data presented in this study provide strong experimental evidence that the polyhydroxystilbene piceatannol represents a promising natural compound with antileukemic properties which might be used in different clinical treatment modalities, such as ex vivo bone marrow purging, 49 or as a new, experimental chemotherapeutic drug in the treatment protocol of childhood ALL.
